Cost-effectiveness of primary and secondary prevention in cardiovascular diseases. [electronic resource]
- European heart journal Apr 1998
- C59-65 p. digital
Publication Type: Journal Article; Review
0195-668X
Cardiovascular Diseases--economics Cost-Benefit Analysis Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors--economics Pravastatin--economics Quality-Adjusted Life Years Risk Assessment Risk Factors Simvastatin--economics